Ocular Therapeutix, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-1
Book Value Per Share
$3
Free Cash Flow Per Share
$-1
Cash Per Share
$4
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-54.9%
Return on Assets
-42.0%
Return on Invested Capital
-44.0%
Current Ratio
15.39
Quick Ratio
15.32
Asset Turnover
0.08
Days Sales Outstanding
215.34
Days Payables Outstanding
230.64
Days Inventory On Hand
197.88
Cash Conversion Cycle
182.58
R&D / Revenue
379.4%
SBC / Revenue
83.1%
Capex / Revenue
23.1%
Working Capital
$731M
Net Current Asset Value
$628M
Invested Capital
$654M
OCF / Net Income
0.77
FCF / Net Income
0.82
Accruals Ratio (Sloan)
-7.6%
Net Debt
$-737M
Net Debt / EBITDA
2.77
Interest Coverage
-22.82
Cash Coverage
-17.31
Capex Coverage
-17.06
Tangible Common Equity
$654M
TCE / Total Assets
81.0%
NOPAT
$-213M
Cash ROIC
-44.7%
WC / Revenue
1407.7%
Capex / D&A
2.78
Reinvestment Rate
-2.8%
Asset Growth vs Revenue Growth
94.9%
Revenue 5Y CAGR
24.4%
Book Value 5Y CAGR
53.8%
Stock Price (FY-end)
$12
Market Cap
$2.27B
P/S Ratio
43.75
P/B Ratio
3.47
P/TB Ratio
3.47
Enterprise Value
$1.54B
EV / Sales
29.57
FCF Yield
-9.5%
Shareholder Yield
-1.9%
R&D Yield
8.7%
Capex Yield
0.5%
Shares Variation (YoY)
18.3%
Beta (5Y)
1.50
Cost of Equity
12.0%
52W High
$16
52W Low
$6
Trailing Return 1Y
43.8%
Trailing Return 5Y
-44.8%
F-Score (Piotroski)
3.00
Z-Score (Altman)
6.91
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.